Sign In
Buy QGEN
$37.56
+1.11 (+3.05%)
At Close: Jun 04, 2026
QIAGEN (QGEN) Q1 Earnings Surpass Estimates, 2022 View Up
12:02pm, Friday, 29'th Apr 2022
QIAGEN (QGEN) exited first-quarter 2022 with better-than-expected results on strength in the non-COVID product portfolio driving the top line.
Stryker (SYK) Q1 Earnings and Revenues Surpass Estimates
11:11am, Friday, 29'th Apr 2022 Zacks Investment Research
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments.
DexCom (DXCM) Q1 Earnings Miss, Revenues Beat Estimates
10:59am, Friday, 29'th Apr 2022 Zacks Investment Research
Despite a decline in bottom line, DexCom's (DXCM) first-quarter results benefit from domestic and international revenue growth and solid new customer additions.
Merit Medical (MMSI) Q1 Earnings Beat, FY22 View Unchanged
04:19pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Merit Medical (MMSI), in the first quarter, benefits from revenue growth in both its segments and from all of the product categories within its Cardiovascular unit.
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q1 2022 Results - Earnings Call Transcript
04:15pm, Thursday, 28'th Apr 2022
QIAGEN N.V. (NYSE:QGEN ) Q1 2022 Earnings Conference Call April 28, 2022 10:00 AM ET Company Participants John Gilardi - VP of Corporate Communications and IR Thierry Bernard - CEO Roland Sackers - CF
Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates
02:54pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Baxter's (BAX) first-quarter results reflect robust performance across four of its business units.
West Pharmaceutical (WST) Q1 Earnings Top Estimates, Revenues Lag
02:52pm, Thursday, 28'th Apr 2022 Zacks Investment Research
West Pharmaceutical's (WST) first-quarter earnings reflect strength in the Proprietary Products segment and operating margin expansion.
Align Technology (ALGN) Q1 Earnings Lag Estimates, Margins Fall
02:32pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Robust Clear Aligner case volume growth and increased uptake of the iTero Element 5D Plus are driving Align Technology's (ALGN) first-quarter top line.
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Down
02:31pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Impressive performance by the Home Health and Hospice segments drove Amedisys' (AMED) revenues in the first quarter.
Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates
12:52pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Abiomed's (ABMD) strength in Impella product revenues drives its Q4 top line.
Qiagen sees no immediate impact from global supply bottlenecks
04:56am, Thursday, 28'th Apr 2022
U.S.-German biotechnology company Qiagen NV said on Thursday it was not currently affected by global supply chain bottlenecks as it had already been stockpiling supplies at its production facilities a
Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates
07:35pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Qiagen (QGEN) delivered earnings and revenue surprises of 12.68% and 6.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates
06:03pm, Tuesday, 26'th Apr 2022
Qiagen (QGEN) delivered earnings and revenue surprises of 12.68% and 6.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ecolab's (ECL) Q1 Earnings in Line, Revenues Beat Estimates
04:34pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Ecolab's (ECL) robust performance across all of its segments drives its Q1 sales despite business challenges.
Catalent (CTLT) to Report Q3 Earnings: What's in the Cards?
04:55pm, Monday, 25'th Apr 2022 Zacks Investment Research
Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.
